# Cyrille Hulin, M.D., Pessac Cedex, France – FDA Inspections

Source: https://www.keypedia.com/companies/cyrille-hulin-md/1bca8520-7969-4017-b2ba-ae4f4e0576c6

> Inspection records and compliance data for Cyrille Hulin, M.D. in Pessac Cedex. 1 FDA inspection on record, last inspected September 06, 2019.

---

## Details

- Name: Cyrille Hulin, M.D.
- FEI Number: 3015447300
- Address Line 1: Centre Hospitalier Regional, Chru - H'Pital Du Haut Lvque - Centre Francois Magendie
- City: Pessac Cedex
- Country Name: France
- Address: Centre Hospitalier Regional, Chru - H'Pital Du Haut Lvque - Centre Francois Magendie, Pessac Cedex, France
- Country: France

## Related Documents

- FDA Inspection 1105936 - Cyrille Hulin, M.D. - 2019-09-06 — classification: No Action Indicated (NAI), source: FDA, date: September 6, 2019

## Related Companies

- [Shiseido International France S.A.S.](https://www.keypedia.com/companies/shiseido-international-france-sas/7ea167ff-ddc0-4f7d-afbe-b07debb9ae05)
- [Yahsou Delmas, MD, PhD](https://www.keypedia.com/companies/yahsou-delmas-md-phd/21dbaf07-88a6-421b-bbb4-9dd8ae07ada2)
- [Osiris G.I.E.](https://www.keypedia.com/companies/osiris-gie/56e7b1f3-74f7-4526-b606-98c16aa51340)
- [Jean-Claude Netter, M.D.](https://www.keypedia.com/companies/jean-claude-netter-md/0df0e390-051b-4c57-b1bd-df1a403b2766)
- [ALLECRA THERAPEUTICS SAS](https://www.keypedia.com/companies/allecra-therapeutics-sas/d55f9fcc-15e3-4648-a74e-36e4babb501d)
- [FACOSPAR](https://www.keypedia.com/companies/facospar/5856c82f-4242-4f9e-8acd-47369cd0431e)
- [Dutriaux, Caroline](https://www.keypedia.com/companies/dutriaux-caroline/cf2f889e-5b06-49e4-b90b-632e2fcb3ead)
- [Professeur Florence Duffaud](https://www.keypedia.com/companies/professeur-florence-duffaud/7383b19a-1393-44e6-bdb6-b5a172b88ca5)
- [Christophe Hezode](https://www.keypedia.com/companies/christophe-hezode/ff0ae2fb-7764-4dd4-8112-c01cca4cb175)
- [Meda Manufacturing S.A.S.](https://www.keypedia.com/companies/meda-manufacturing-sas/7a48c90f-aa3d-484a-b55e-88a5e2448536)